<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>High-resolution computed tomography patterns in idiopathic pulmonary fibrosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">High-resolution computed tomography patterns in idiopathic pulmonary fibrosis</h1>
<div class="graphic"><div class="figure"><div class="ttl">High-resolution computed tomography patterns in idiopathic pulmonary fibrosis</div><div class="cntnt"><table cellspacing="0"><colgroup width="12%"></colgroup><colgroup span="4" width="22%"></colgroup> <tbody> <tr> <td class="subtitle1" rowspan="2"> </td> <td class="subtitle1" colspan="4">HRCT pattern</td> </tr> <tr> <td class="subtitle2">UIP pattern</td> <td class="subtitle2">Probable UIP pattern</td> <td class="subtitle2">Indeterminate for UIP</td> <td class="subtitle2">CT findings suggestive of an alternative diagnosis</td> </tr> <tr> <td><strong>Level of confidence for UIP histology</strong></td> <td> <ul> <li>Confident (&gt;90%)</li> </ul> </td> <td> <ul> <li>Provisional high confidence (70-89%)</li> </ul> </td> <td> <ul> <li>Provisional low confidence (51-69%)</li> </ul> </td> <td> <ul> <li>Low to very low confidence (≤50%)</li> </ul> </td> </tr> <tr class="highlight_lght_gray_text"> <td><strong>Distribution</strong></td> <td> <ul> <li>Subpleural and basal predominant</li> <li>Often heterogeneous (areas of normal lung interspersed with fibrosis)</li> <li>Occasionally diffuse</li> <li>May be asymmetric</li> </ul> </td> <td> <ul> <li>Subpleural and basal predominant</li> <li>Often heterogeneous (areas of normal lung interspersed with reticulation and traction bronchiectasis/<br/> bronchiolectasis)</li> </ul> </td> <td> <ul> <li>Diffuse distribution without subpleural predominance</li> </ul> </td> <td> <ul> <li>Peribronchovascular predominant with subpleural sparing (consider NSIP)</li> <li>Perilymphatic distribution (consider sarcoidosis)</li> <li>Upper or mid lung (consider fibrotic HP, CTD-ILD, and sarcoidosis)</li> <li>Subpleural sparing (consider NSIP or smoking-related IP)</li> </ul> </td> </tr> <tr> <td><strong>CT features</strong></td> <td> <ul> <li>Honeycombing with or without traction bronchiectasis/<br/> bronchiolectasis</li> <li>Presence of irregular thickening of interlobular septa</li> <li>Usually superimposed with a reticular pattern, mild GGO</li> <li>May have pulmonary ossification</li> </ul> </td> <td> <ul> <li>Reticular pattern with traction bronchiectasis/<br/> bronchiolectasis</li> <li>May have mild GGO</li> <li>Absence of subpleural sparing</li> </ul> </td> <td> <ul> <li>CT features of lung fibrosis that do not suggest any specific etiology</li> </ul> </td> <td> <ul> <li>Lung findings <ul> <li>Cysts (consider LAM, PLCH, LIP, and DIP)</li> <li>Mosaic attenuation or three-density sign (consider HP)</li> <li>Predominant GGO (consider HP, smoking-related disease, drug toxicity, and acute exacerbation of fibrosis)</li> <li>Profuse centrilobular micronodules (consider HP or smoking-related disease)</li> <li>Nodules (consider sarcoidosis)</li> <li>Consolidation (consider organizing pneumonia)</li> </ul> </li> <li>Mediastinal findings <ul> <li>Pleural plaques (consider asbestosis)</li> <li>Dilated esophagus (consider CTD)</li> </ul> </li> </ul> </td> </tr> </tbody></table></div><div class="graphic_lgnd">The previous term, "early UIP pattern," has been eliminated to avoid confusion with "interstitial lung abnormalities" described in the text. The term "indeterminate for UIP" has been retained for situations in which the HRCT features do not meet UIP or probable UIP criteria and do not explicitly suggest an alternative diagnosis.</div><div class="graphic_footnotes">CT: computed tomography; CTD: connective tissue disease; DIP: desquamative interstitial pneumonia; GGO: ground-glass opacity; HP: hypersensitivity pneumonitis; HRCT: high-resolution computed tomography; ILD: interstitial lung disease; IP: interstitial pneumonia; LAM: lymphangioleiomyomatosis; LIP: lymphoid interstitial pneumonia; NSIP: nonspecific interstitial pneumonia; PLCH: pulmonary Langerhans cell histiocytosis; UIP: usual interstitial pneumonia.</div><div class="graphic_reference">Reprinted with permission of the American Thoracic Society. Copyright © 2022 American Thoracic Society. All rights reserved. From: Raghu G, Remy-Jardin M, Richeldi L, et al. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med 2022; 205(9):e18-e47. The American Journal of Respiratory and Critical Care Medicine is an official journal of the American Thoracic Society.</div><div id="graphicVersion">Graphic 107407 Version 5.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
